Varenicline-d 4

Overview

Varenicline-d 4 is deuterium labeled Varenicline. Varenicline (CP 526555) is a potent partial agonist for α4β2 nicotinic acetylcholine receptor ( nAChR ) with an EC 50 value of 2.3 μM. Varenicline is a full agonist for α3β4 and α7 nAChRs with EC 50 values of 55 μM and 18 μM, respectively. Varenicline is a nicotinic ligand based on the structure of cytisine, has the potential for smoking cessation treatment.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > nAChR

Product Information

• Catalog No.: HY-10019S
• CAS No.: 2183239-01-0
• Molecular Formula: C13H9D4N3
• Molecular Weight: 215.29
• Purity: 99.98%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source